Education
About Us
Working with TipRanks
Follow Us
Abpro Holdings (ABP)
NASDAQ:ABP
ABP Stock Chart & Stats
$5.62
-$0.18(-12.24%)
At close: 4:00 PM EST
$5.62
-$0.18(-12.24%)
Day’s Range― - ―
52-Week Range$4.53 - $371.40
Previous Close$1.32
Volume347.98K
Average Volume (3M)4.50M
Market Cap
$14.24M
Enterprise ValueN/A
Total Cash (Recent Filing)$2.01M
Total Debt (Recent Filing)$2.23M
Price to Earnings (P/E)―
Beta1.61
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding2,672,222
10 Day Avg. Volume2,638,066
30 Day Avg. Volume4,496,030
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)-1.09
Price to Sales (P/S)91.93
P/FCF Ratio-1.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Financial FlexibilityThere is access to a $50M equity line of credit, which may help address capital needs.
Strategic PartnershipsAbpro has partnered with Celltrion, incurring no clinical costs and sharing profits 50/50.
Bears Say
Capital NeedsLimited news flow and near-term capital needs create strategic uncertainty for Abpro Holdings.
Cash Reserve ConcernsAbpro ended the quarter with $2.1M in cash and a cash burn trend over $2M per quarter, indicating a need for additional capital.
Strategic UncertaintyDowngrading Shares to Hold on Strategic Uncertainty and Financing Overhang.
Abpro Holdings News
ABP FAQ
What was Abpro Holdings’s price range in the past 12 months?
Abpro Holdings lowest stock price was $4.53 and its highest was $371.40 in the past 12 months.
What is Abpro Holdings’s market cap?
Abpro Holdings’s market cap is $14.24M.
When is Abpro Holdings’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Abpro Holdings’s earnings last quarter?
Currently, no data Available
Is Abpro Holdings overvalued?
According to Wall Street analysts Abpro Holdings’s price is currently Overvalued.
Does Abpro Holdings pay dividends?
Abpro Holdings does not currently pay dividends.
What is Abpro Holdings’s EPS estimate?
Abpro Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Abpro Holdings have?
Abpro Holdings has 2,672,222 shares outstanding.
What happened to Abpro Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Abpro Holdings?
Currently, no hedge funds are holding shares in ABP
Company Description
Abpro Holdings
Abpro Holdings, Inc., a biotechnology company, engages in developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and autoimmunity issues. Its platform DiversImmune addresses a bottleneck in the antibody therapeutics industry. Its lead product candidates include ABP-100 for the treatment of breast, gastric, and colorectal cancers; and ABP-201 for the treatment of vascular diseases of the eye. The company has a strategic partnership with Abpro Bio Co. Ltd and NJCTTQ. The company was formerly known as Abpro Corporation and changed its name to Abpro Holdings, Inc. in November 2024. Abpro Holdings, Inc. was incorporated in 2004 and is headquartered in Woburn, Massachusetts.
ABP Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Can-Fite BioPharma
―
XTL Biopharmaceuticals Sponsored ADR
―
Cellectar Biosciences
―
Cocrystal Pharma
―
Sensei Biotherapeutics
―
Ownership Overview
11.69% Insiders
0.20% Mutual Funds
1.25% Other Institutional Investors
86.46% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---